220 related articles for article (PubMed ID: 1971431)
21. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
22. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102
[TBL] [Abstract][Full Text] [Related]
23. Opioid regulation of mucosal ion transport in the mouse isolated jejunum.
Sheldon RJ; Rivière PJ; Malarchik ME; Moseberg HI; Burks TF; Porreca F
J Pharmacol Exp Ther; 1990 Apr; 253(1):144-51. PubMed ID: 2329501
[TBL] [Abstract][Full Text] [Related]
24. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC
Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
[TBL] [Abstract][Full Text] [Related]
25. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell cultures.
Chen GG; Chalazonitis A; Shen KF; Crain SM
Brain Res; 1988 Oct; 462(2):372-7. PubMed ID: 2847853
[TBL] [Abstract][Full Text] [Related]
26. Arylacetamide kappa-opioid receptor agonists produce a tonic- and use-dependent block of tetrodotoxin-sensitive and -resistant sodium currents in colon sensory neurons.
Joshi SK; Lamb K; Bielefeldt K; Gebhart GF
J Pharmacol Exp Ther; 2003 Oct; 307(1):367-72. PubMed ID: 12954815
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
28. Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro.
Inenaga K; Nagatomo T; Nakao K; Yanaihara N; Yamashita H
Neuroscience; 1994 Jan; 58(2):331-40. PubMed ID: 7908725
[TBL] [Abstract][Full Text] [Related]
29. Kappa opiate agonists inhibit Ca2+ influx in rat spinal cord-dorsal root ganglion cocultures. Involvement of a GTP-binding protein.
Attali B; Saya D; Nah SY; Vogel Z
J Biol Chem; 1989 Jan; 264(1):347-53. PubMed ID: 2535841
[TBL] [Abstract][Full Text] [Related]
30. Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.
Shen KF; Crain SM
Brain Res; 1995 Feb; 673(1):30-8. PubMed ID: 7757476
[TBL] [Abstract][Full Text] [Related]
31. Effect of opioid peptides on circular muscle of canine duodenum.
Bauer AJ; Szurszewski JH
J Physiol; 1991 Mar; 434():409-22. PubMed ID: 1673718
[TBL] [Abstract][Full Text] [Related]
32. Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons.
Moises HC; Rusin KI; Macdonald RL
J Neurosci; 1994 Oct; 14(10):5903-16. PubMed ID: 7931552
[TBL] [Abstract][Full Text] [Related]
33. Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors.
Shen KF; Crain SM
Brain Res; 1990 Aug; 525(2):225-31. PubMed ID: 2174711
[TBL] [Abstract][Full Text] [Related]
34. Vasopressin modulates cerebrovascular responses to opioids in newborn pigs.
Armstead WM; Mirro R; Zuckerman SL; Leffler CW
J Pharmacol Exp Ther; 1992 Mar; 260(3):1107-12. PubMed ID: 1347565
[TBL] [Abstract][Full Text] [Related]
35. Dynorphin reduces calcium-dependent action potential duration by decreasing voltage-dependent calcium conductance.
Werz MA; Macdonald RL
Neurosci Lett; 1984 May; 46(2):185-90. PubMed ID: 6146120
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
Ramme D; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
[TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin octapeptide reverses the kappa-opioid-receptor-mediated depression of calcium current in rat dorsal root ganglion neurons.
Xu T; Liu NJ; Li CQ; Shangguan Y; Yu YX; Kang HG; Han JS
Brain Res; 1996 Aug; 730(1-2):207-11. PubMed ID: 8883905
[TBL] [Abstract][Full Text] [Related]
38. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
[TBL] [Abstract][Full Text] [Related]
39. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside.
Crain SM; Shen KF
Brain Res; 1992 Mar; 575(1):13-24. PubMed ID: 1324084
[TBL] [Abstract][Full Text] [Related]
40. Opioids at low concentration decrease openings of K+ channels in sensory ganglion neurons.
Fan SF; Shen KF; Crain SM
Brain Res; 1991 Aug; 558(1):166-70. PubMed ID: 1682013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
